FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Mankind Pharma IPO and Tata Technologies IPO.
Mankind Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Tata Technologies IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Mankind Pharma IPO | Tata Technologies IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Kotak Mahindra Capital Company Limited Axis Capital Limited Iifl Securities Ltd Jefferies India Private Limited J.P. Morgan India Private Limited |
Jm Financial Limited Citigroup Global Markets India Private Limited Bofa Securities India Limited |
Registrar | Kfin Technologies Limited | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Mankind Pharma IPO is up to ₹4,326.36 Cr whereas the issue size of the Tata Technologies IPO is up to ₹3,042.51 Cr. The final issue price of Mankind Pharma IPO is ₹1,080.00 per share and of Tata Technologies IPO is ₹500.00 per share.
Mankind Pharma IPO | Tata Technologies IPO | |
---|---|---|
Face Value | ₹1 per share | ₹2 per share |
Issue Price (Lower) | ₹1,026.00 per share | ₹475.00 per share |
Issue Price (Upper) | ₹1,080.00 per share | ₹500.00 per share |
Issue Price (Final) | ₹1,080.00 per share | ₹500.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 13 shares | 30 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | ||
OFS Issue Size | 4,00,58,844 shares | 6,08,50,278 shares |
OFS Issue Size (Amount) | up to ₹4,326.36 Cr | up to ₹3,042.51 Cr |
Issue Size Total | 4,00,58,844 shares | 6,08,50,278 shares |
Issue Size Total (Amount) | up to ₹4,326.36 Cr | up to ₹3,042.51 Cr |
Mankind Pharma IPO opens on Apr 25, 2023, while Tata Technologies IPO opens on Nov 22, 2023. The closing date of Mankind Pharma IPO and Tata Technologies IPO is Apr 27, 2023, and Nov 24, 2023, respectively.
Mankind Pharma IPO | Tata Technologies IPO | |
---|---|---|
Anchor Bid Date | Apr 24, 2023 | Nov 21, 2023 |
Issue Open | Apr 25, 2023 | Nov 22, 2023 |
Issue Close | Apr 27, 2023 | Nov 24, 2023 |
Basis Of Allotment (Tentative) | May 03, 2023 | Nov 28, 2023 |
Initiation of Refunds (Tentative) | May 04, 2023 | Nov 29, 2023 |
Credit of Share (Tentative) | May 05, 2023 | Nov 29, 2023 |
Listing date (Tentative) | May 09, 2023 | Nov 30, 2023 |
Anchor Lockin End date 1 | Jun 02, 2023 | Dec 28, 2023 |
Anchor Lockin End date 2 | Aug 01, 2023 | Feb 26, 2024 |
Mankind Pharma IPO P/E ratio is 32.5, as compared to Tata Technologies IPO P/E ratio of 32.53.
Mankind Pharma IPO | Tata Technologies IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
Tata Technologies Limited Financial Information (Restated Consolidated)Tata Technologies Limited's revenue increased by 25.81% and profit after tax (PAT) rose by 42.8% between the financial year ending with March 31, 2023 and March 31, 2022.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 79.00% | 66.79% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 76.50% | 55.39% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 32.5 | 32.53 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹43263.60 Cr. | ₹20283.43 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 27.60%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 26.10%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹33.20 | ₹15.37 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 27.70%% | 20.87%% |
In the Mankind Pharma IPO retail investors (RII) are offered 1,40,20,596 shares while in Tata Technologies IPO retail investors are offered 1,40,20,596 shares. Qualified institutional buyers (QIB) are offered 80,11,769 shares in Mankind Pharma IPO and 1,05,47,382 shares in Tata Technologies IPO.
Mankind Pharma IPO | Tata Technologies IPO | |
---|---|---|
Anchor Investor Reserveration | 1,20,17,652 shares | 1,58,21,071 shares |
Market Maker Reserveration | ||
QIB | 80,11,769 shares | 1,05,47,382 shares |
NII | 60,08,827 shares | 79,10,537 shares |
RII | 1,40,20,596 shares | 1,84,57,919 shares |
Employee | 0 shares | 20,28,342 shares |
Others | ||
Total | 2,80,41,192 shares | 4,50,29,207 shares |
Mankind Pharma IPO subscribed 15.32x in total, whereas Tata Technologies IPO subscribed 69.43x.
Mankind Pharma IPO | Tata Technologies IPO | |
---|---|---|
QIB (times) | 49.16x | 203.41x |
NII (times) | 3.80x | 62.11x |
Big NII (times) | 4.99x | 70.67x |
Small NII (times) | 1.41x | 44.98x |
RII (times) | 0.92x | 16.50x |
Employee (times) | 3.70x | |
Other (times) | 29.20x | |
Total (times) | 15.32x | 69.43x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|